Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial

BACKGROUND: In Japan, transarterial infusion chemotherapy using cisplatin (CDDP-TAI) is frequently used for advanced hepatocellular carcinoma (HCC). Moreover, oral chemotherapy with S-1, an oral fluoropyrimidine derivative, has also elicited promising responses in HCC patients. We determined the rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Terazawa, Tetsuji, Kondo, Shunsuke, Hosoi, Hiroko, Morizane, Chigusa, Shimizu, Satoshi, Mitsunaga, Shuichi, Ikeda, Masafumi, Ueno, Hideki, Okusaka, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011764/
https://www.ncbi.nlm.nih.gov/pubmed/24779747
http://dx.doi.org/10.1186/1471-2407-14-301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011764/
https://www.ncbi.nlm.nih.gov/pubmed/24779747
http://dx.doi.org/10.1186/1471-2407-14-301

Ejemplares similares